A federal civil lawsuit claims a major pharmaceutical company misrepresented clinical data and used sham litigation to maintain a monopoly over a drug used to treat depression and anxiety. Uniondale Chemists Inc., a retail pharmacy in Uniondale, N.Y., filed the lawsuit in U.S. District Court in Mississippi against Wyeth L.L.C., now part of Pfizer Inc. Pfizer denied the allegations, saying it stands behind "its Effexor XR portfolio, which represents an important innovation in the treatment of depression and anxiety and has benefited millions of patients." - AP